Avantor, Inc.
NYSE:AVTRMedical - Instruments & Supplies
+$0.07 today
- Market cap
- $10.41B
- Beta
- 0.96
- P/E (TTM)
- -11.7
- EPS (TTM)
- -$0.81
Volume 5.94M
Average 9.44M
AVTR Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Avantor, Inc.NYSE: AVTR
Revenue · Q2 FY2026 · quarter ended Jun 2026
Revenue growth accelerates
Q2 FY2026 revenue of $1.69B rose 0.5% year over year, ahead of the -1.6% change in trailing-twelve-month revenue. Sequentially, it rose 7.0% from the prior quarter. Over 3 fiscal years it compounded at -4.5% a year.
Context
- Revenue increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 11 analysts of $6.67B (+1.8%) for the fiscal year ending Dec 2026, a step up from the -3.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.69B+7.0% QoQ
- Last fiscal yearDec 2025
- $6.55B-3.4% YoY
- LTMJun 2026
- $6.56B-1.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +0.5% | +1.2% | +0.6 pp |
| 1 year | -3.4% | +1.8% | +5.2 pp |
| 3-year CAGR | -4.5% | +2.8% | +7.2 pp |
| 5-year CAGR | +3.0% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 6.55B USD
- Year-over-year change
- -3.4%
- 4-year CAGR
- -3.0%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.55B | -3.4% |
| FY2024 | 2024-12-31 | 6.78B | -2.6% |
| FY2023 | 2023-12-31 | 6.97B | -7.3% |
| FY2022 | 2022-12-31 | 7.51B | +1.7% |
| FY2021 | 2021-12-31 | 7.39B | — |
Revenue vs competitors
How AVTR compares with its peers on the latest reported figures
- Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
- Its year-over-year change of -1.6% is the lowest of 9, against a peer median of +6.1%.
- Over three fiscal years its annual growth of -4.5% compares with a peer median of -0.9%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $25.61B USD | +5.5% | -2.7% | |
| LTM Jun 2026 | $6.56B USD | -1.6% | -4.5% | |
| LTM Jun 2026 | $4B USD | -0.7% | +0.3% | |
| LTM Jun 2026 | $3.33B USD | +12.4% | +2.1% | |
| LTM Jun 2026 | $2.59B USD | +1.4% | -2.7% | |
| LTM Jun 2026 | €1.22B EUR | +6.7% | +5.0% | |
| LTM Jun 2026 | $785.1M USD | +16.5% | -2.7% | |
| LTM Sep 2026 | $621.7M USD | +4.7% | -2.2% | |
| LTM Mar 2026 | $99.77M USD | +40.9% | +8.1% | |
| Peer median (excluding AVTR) | — | +6.1% | -0.9% | |
Competitors are the stored peer set for AVTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 7.39B | 7.51B | 6.97B | 6.78B | 6.55B |
| Cost of Revenue | 4.88B | 4.91B | 4.6B | 4.5B | 4.41B |
| Gross Profit | 2.5B | 2.6B | 2.36B | 2.28B | 2.14B |
| Gross Margin | 33.9% | 34.6% | 33.9% | 33.6% | 32.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.53B | 1.47B | 1.51B | 1.64B | 1.6B |
| Operating Expenses | 1.53B | 1.47B | 1.67B | 1.19B | 2.39B |
| Depreciation & Amortization | 379.2M | 405.5M | 402.3M | 405.5M | 410.2M |
| EBITDA | 1.35B | 1.52B | 1.1B | 1.48B | 138.7M |
| EBITDA Margin | 18.3% | 20.3% | 15.8% | 21.8% | 2.1% |
| Operating Income | 972.2M | 1.13B | 696.4M | 1.08B | (246.2M) |
| Operating Margin | 13.2% | 15.0% | 10.0% | 16.0% | -3.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 217.4M | 265.8M | 284.8M | 218.8M | 169.8M |
| Other Income / Expenses | (219.2M) | (279.1M) | (285.9M) | (230.9M) | (195.1M) |
| Income Before Tax | 753M | 851.1M | 410.5M | 853.9M | (441.3M) |
| Pre-Tax Margin | 10.2% | 11.3% | 5.9% | 12.6% | -6.7% |
| Income Tax Expense | 180.4M | 164.6M | 89.4M | 142.4M | 88.9M |
| Net Income | 572.6M | 686.5M | 321.1M | 711.5M | (530.2M) |
| Net Margin | 7.8% | 9.1% | 4.6% | 10.5% | -8.1% |
| EPS (Basic) | 0.86 | 1.02 | 0.48 | 1.05 | (0.78) |
| EPS (Diluted) | 0.85 | 1.01 | 0.47 | 1.04 | (0.78) |
| Weighted Avg Shares | 590.5M | 650.9M | 675.6M | 680.3M | 678M |
| Weighted Avg Shares (Diluted) | 599.6M | 679.4M | 678.4M | 681.9M | 679.3M |
Avantor, Inc.
NYSE:AVTR
Intrinsic Alpha fair value
Locked
Current Price
$15.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.